PublISHED ON 10 December 2020
UpDATED ON 10 December 2020
Funding without focus requirement led to ground-breaking research
By offering funding for up to nine years, MIMS could recruit promising researchers from across the world – Emmanuelle Charpentier’s discovery shows that the strategy was successful.
One of the people celebrated today in the digital ceremony that replaces the Nobel Prize ceremony is Emmanuelle Charpentier. Together with Jennifer A. Doudna, she is this year’s winner of the Nobel Prize in Chemistry. Their discoveries of the genetic scissors CRISPR/Cas9 have revolutionised molecular life sciences by making it possible to change the genome of animals, plants and micro-organisms.
When Emmanuelle Charpentier, who is today a professor, scientific leader and head of the Max Planck Unit for the Science of Pathogens in Berlin, made her ground-breaking discoveries, she was working at the MIMS laboratory at Umeå University. She was one of the first team leaders the laboratory recruited in 2008.
Oliver Billker, who is a professor at the Department of Molecular Biology at Umeå University and the current head of MIMS, describes how the funding from the Swedish Research Council opened a new door to recruiting researchers.
“By offering grants lasting up to nine years, we can attract the most promising researchers from anywhere in the world to apply. Here, they have the opportunity to build up a high-quality research environment and the freedom to tackle big and important questions.”
“Emmanuelle Charpentier’s discovery shows that this plan succeeded,” says Oliver Billker.
“When she started her laboratory at MIMS, her potential as a scientist was apparent, but the enormous significance that her ongoing research would quickly develop could not have been predicted.”
MIMS still receives funding from the Swedish Research Council. Oliver Billker underlines the importance of grants without a required focus, how this stimulates creative and curiosity-driven research.
“Many of the best scientists are motivated by their curiosity. Their research often leads to profound discoveries, the importance of which was not predictable. The discovery of CRISPR/Cas9 is a great example. The recent successes in vaccine development demonstrate that science can deliver products at great speed. However, this only works because of the enormous body of knowledge generated by previous curiosity-driven research.”
Emmanuelle Charpentier worked at MIMS, the Laboratory for Molecular Infection Medicine Sweden, at Umeå University with funding from the Swedish Research Council during 2008–2013. MIMS is one of the nodes in the Nordic network operated by the European Molecular Biology Laboratory, EMBL.
This year’s Nobel Prizes are given out in the prize winners’ home countries. On Monday 7 December, Emmanuelle Charpentier received her diploma and medal at the Swedish Embassy in Berlin.
On Tuesday 8 December, she and Jennifer A. Doudna gave their Nobel lectures.
On 10 December, all Nobel Prize winners are celebrated simultaneously at a digital ceremony broadcast from Stockholm City Hall.
PUBLISHED ON 10 December 2020
UpDATED ON 10 December 2020
Pdf / Printout
MORE WITHIN THE SAME SUBJECT AREA
Published 16 April 2021
The research environments that received funding under the Swedish Research Council’s ten-year investment in strong research environments have reached their midterm point. A successful initiative that fulfils the goals in the opinion of an internation...
Published 14 April 2021
In autumn 2020, the Swedish Research Council reviewed its two committees within clinical research. The review resulted in a number of recommendations to the Government, including the closing down of the Committee for Clinical Studies, which has now b...
Published 13 April 2021
During 2019–2020, the Swedish Research Council carried out a mid-term evaluation of the implementation of the grant International recruitment of distinguished researchers, which was announced in 2013 and 2014. The purpose of the evaluation of the 19...